CERUS CORP
Develops pathogen reduction technology to safeguard the global blood supply for healthcare providers.
CERS | NDAQ
Overview
Corporate Details
- ISIN(s):
- US1570851014
- LEI:
- Country:
- United States of America
- Address:
- 1220 CONCORD AVENUE, 94520 CONCORD
- Website:
- https://www.cerus.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Cerus Corporation is a biomedical products company dedicated to safeguarding the world's blood supply. The company develops and commercializes the INTERCEPT Blood System, a technology designed to inactivate a broad range of pathogens in donated blood components, such as platelets and plasma. By reducing the risk of transfusion-transmitted infections, the system aims to enhance the safety and availability of blood products for patients. Cerus partners with blood centers, hospitals, and other healthcare providers globally to implement its pathogen reduction technology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CERUS CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CERUS CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CERUS CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
